Biotech

All Articles

Lykos will definitely ask FDA to reconsider its own decision following denial of MDMA therapy for post-traumatic stress disorder

.Adhering to an inadequate presenting for Lykos Therapies' MDMA candidate for post-traumatic stress ...

AN 2 halves roll call, ceases stage 3 trial after records disappoint

.AN2 Rehabs is actually reviewing its company in feedback to uninspired midphase records, promising ...

Merck pays for $700M for bispecific, snooping autoimmune opening as well as opportunity to challenge Amgen in cancer

.Merck &amp Co. is actually paying for $700 thousand in advance to challenge Amgen in a blood cancer...

Gilead pays J&ampJ $320M to leave licensing deal for seladelpar

.With Gilead Sciences about to an FDA decision for its liver health condition medicine seladelpar, t...

' All hands on deck' at Lilly as peers target obesity market

.Chief executive officer David Ricks can easily see the business setting up camping tents at basecam...

Entero laying off staff, leaving office and also pausing R&ampD

.Bed Liquidators has transformed Entero Therapeutics white as a piece. The collector bought Entero t...

Exelixis falls ADC after determining it's no match for Tivdak

.Exelixis is actually surrendering on its tissue element (TF)- targeting antibody-drug conjugate aft...

Relay loses interest in SHP2 inhibitor after Genentech leaves behind

.3 weeks after Roche's Genentech device bowed out an SHP2 prevention pact, Relay Therapy has affirme...

Stoke's Dravet syndrome med launched of partial scientific hold

.Stoke Rehabs' Dravet disorder medicine has been actually without a partial hold, getting rid of the...

Fierce Biotech's Gabrielle Masson provides Fierce 15 at NYSE

.Fierce Biotech Partner Editor Gabrielle Masson offered the 2024 course of Strong 15 victors on the ...